1 option
Risks from ebola discharge from hospitals to sewer workers / by Kyle Bibby, Ph.D. [and three others].
- Format:
- Book
- Author/Creator:
- Bibby, Kyle, author.
- Series:
- WERF Research Report Series
- WERF Research Report Series ; v.WERF4C15
- Language:
- English
- Subjects (All):
- Ebola virus disease.
- Bacterial diseases.
- Hemorrhagic Fever, Ebola.
- Medical Subjects:
- Hemorrhagic Fever, Ebola.
- Physical Description:
- 1 online resource (64 pages) : illustrations, tables
- Edition:
- 1st ed.
- Place of Publication:
- Alexandria, Virginia : WERF, 2016.
- Summary:
- Current World Health Organization and Centers for Disease Control and Prevention guidance for the disposal of liquid waste from patients undergoing treatment for Ebola virus disease at hospitals in the United States is to manage patient excreta as ordinary wastewater without pretreatment.
- Contents:
- Cover
- Copyright
- Acknowledgments
- Abstract and Benefits
- Table of Contents
- List of Tables
- List of Figures
- List of Abbreviations and Acronyms
- Executive Summary
- Chapter 1.0: Study Significance
- Chapter 2.0: Quantitative Microbial Risk Assessment
- 2.1 Introduction
- 2.2 Materials and Methods
- 2.2.1 Exposure Assessment
- 2.2.2 Dose-Response Assessment
- 2.2.3 Risk Characterization
- 2.3 Results and Discussion
- 2.3.1 Exposure Assessment
- 2.3.1.1 Patient Excreta and Secreta Production to Sewer
- 2.3.1.2 Excreta and Secreta Concentrations of EBOV
- 2.3.1.3 Hospital Daily Outflow (For internal dilution rate in hospital)
- 2.3.1.4 Interceptor Daily Flow (For dilution from hospital discharge to sewer to point of worker exposure)
- 2.3.1.5 EBOV Die-Off Rate
- 2.3.1.6 Sewer Travel Time from Patient to Point of Worker Exposure
- 2.3.1.7 Partition Coefficient (Ratio of aerosol concentration of EBOV to liquid concentration)
- 2.3.1.8 Respirable Fraction (Fraction of aerosols generated that are respirable)
- 2.3.1.9 Worker Inhalation Rate
- 2.3.1.10 EBOV Removal Fraction by Worker PPE
- 2.3.1.11 Time Spent by a Sewer Worker in the Proximity
- 2.3.1.12 Conversion from EBOV RNA Copies to PFUs
- 2.3.1.13 Dose of Respirable EBOV Inhaled and Retained in Lungs per Exposure
- 2.3.2 Dose-Response Assessment
- 2.3.3 Risk Characterization
- 2.4 Conclusions
- Chapter 3.0: Inactivation Review
- 3.1 Background and Results
- Appendix A: Ebola Risks/Discharge Frequently Asked Questions
- Appendix B: Inactivation Matrix
- Glossary of Terms
- References.
- Notes:
- Includes bibliographical references.
- Description based on online resource; title from PDF title page (ebrary, viewed November 24, 2016).
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 1-78040-831-5
- OCLC:
- 963568305
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.